Role of endothelium in the endothelin-1-mediated potentiation of the norepinephrine response in the aorta of hypertensive rats

Journal of Hypertension

Volumn 15, Issue 10, 1997, Pages 1101-1111

  Zerrouk, Abdellatif ^a   Champeroux, Pascal ^b   Safar, Michel ^a   Brisac, Anne Marie ^a  

^a INSERM   (France)

^b Centre de Recherches Biologiques   (France)

Author keywords

Aorta; Endothelin 1; Endothelium; Genetic hypertension; Norepinephrine; Vascular reactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN; CALCIUM ION; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE; NIFEDIPINE; NORADRENALIN; PIROXICAM; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; HEREDITARY HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0030883549     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715100-00008     Document Type: Article

References (50)

1. Lüscher TF: The endothelium in hypertension: bystander, target or mediator? J Hypertens 1994, 12 (suppl 10):S105-S116.
2. Konishi M, Su C: Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983, 5:881-886.
3. Sim MK, Singh M: Decreased responsiveness of the aortae of hypertensive rats to acetylcholine, histamine, and noradrenaline. Br J Pharmacol 1987, 90:147-150.
4. Watt PAC, Thurston H: Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rat arteries. J Hypertens 1989, 7:661-666.
5. Panza JA, Casino PR, Kilocoyne CM, Quyyumi AA: Impaired endothelium-dependent vasodilatation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol 1994, 23:1610-1616.
6. Auch-Schwelk W, Vanhoutte PM: Endothelium-derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat Am J Hypertens 1991, 4:769-772.
7. Lüscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1989, 8:344-348.
8. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347-504.
9. Bohr DF, Webb RC: Vascular smooth muscle membrane in hypertension. Annu Rev Pharmacol Toxicol 1988, 28:389-409.
10. Shepherd JT: Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypertens 1990 8 (suppl 7):S15-S27.
11. Evenwel RT, Kasbergen CM, Struyker-Boudier HH: Central and regional hemodynamics and plasma volume distribution during the development of spontaneous hypertension in rats. Clin Exp Hypertens 1983, 5:1511-1536.
12. Martel E, Champeroux P, Brisac AM, Magnier A, Richard S, Safar M: Pressor responses to endothelin-1 in normotensive and spontaneously hypertensive rats. Neurochem Int 1991, 18:553-557.
13. Schiffrin EL: Endothelin, potential role in hypertension and vascular hypertrophy. Hypertension 1995, 25:1135-1143.
14. Yang Z, Richard V, Von Segesser L, Bauer E, Stulz P, Turina M, et al.: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm. Circulation 1990, 82:188-195.
15. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Higashimori K, Mikami H, et al.: Effects of endothelin on neuroeffector junction in mesenteric arteries of hypertensive rats. Hypertension 1990, 15:739-743.
16. Reid JJ, Vo PA, Lieu AT, Wong-Dusting HK, Rand MJ: Modulation of norepinephrine-induced vasoconstriction by endothelin-1 and nitric oxide in rat tail artery. J Cardiovasc Pharmacol 1991, 17 (suppl 7):S272-S275.
17. Henrion D, Laher I: Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension 1993, 22:78-83.
18. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992, 19:131-137.
19. James GM, Hodgson WC: Potentiation by endothelin-1 of 5-hydroxytryptamine responses in aortae from streptozotocin-diabetic rats: a role for thromboxane A2. Br J Pharmacol 1995, 114:1236-1240.
20. Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T: Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat Hypertension 1990, 15:475-481.
21. Tadei S, Vanhoutte PM: Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension 1993, 21:9-15.
22. Asano H, Shimizu K, Muramatsu M, Iwama Y, Toki Y, Miyazaki Y, et al.: Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction. J Hypertens 1994, 12:383-390.
23. Hollenberg SM, Tong W, Shelhamer JH, Lawrence M, Cunnion RE: Eicosanoid production by human aortic endothelial cells in response to endothelin. Am J Physiol 1994, 267:H2290-H2296.
24. Morinelli TA, Oatis JE, Okwu AK, Mais DE, Halushka P: Characterization of an 125I-labelled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther 1989, 251:557-562.
25. 2 in the SHR aorta. Circ Res 1995, 76:1003-1010.
26. A receptor. Life Sci 1992, 50:247-255.
27. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, et al.: Biochemical and pharmacological profile of a potent and selective endothelin-B receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994, 91:4892-4896.
28. A receptors in endothelial cells in situ on the aortic side of porcine aortic valve. Br J Pharmacol 1995, 115:1369-1376.
29. Moreau P, Takase H, Lüscher TF: Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor. Br J Pharmacol 1996, 118:1429-1432.
30. Zerrouk A, Auguet M, Delaflotte S, Chabrier P: Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting activity in the rabbit basilar artery: Naunyn-Schmiedebergs Arch Pharmacol 1996, 354:466-473.
31. Zerrouk A, Auguet M, Chabrier P: Role of inducible prostanoids in the vascular response to angiotensin II: Br J Pharmacol 1995, 114:81P.
32. Day MD, Moore AF: Interaction of angiotensin II with noradrenaline and other spasmogens on rabbit isolated aortic strips. Arch Int Pharmacodyn 1976, 219:29-44.
33. Duckles SP: Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci 1981, 28:41-47.
34. Weber MA, Purdy RE, Stupecky GL, Prins BA: Augmentation of sympathomimetic arterial contraction by angiotensin II: a novel mechanism. J Vasc Med Biol 1989, 37:7-12.
35. Dunn WR, Daly CJ, McGrath JC, Wilson VG: A comparison of the effects of angiotensin II and BAY K 8644 on responses to noradrenaline mediated via postjunctional α1- and α2-adrenoceptors in rabbit isolated blood vessels. Br J Pharmacol 1991, 103:1475-1483.
36. 2+ influx: role of protein kinase C. J Pharmacol Exp Ther 1992, 261:835-840.
37. Eikenburg DC, Ekas RD, Lokhandwala MF: Strain differences in the facilitatory action of angiotensin on noradrenergic transmission in the rat mesentery. Clin Exp Hypertens [A] 1981, 3:1039-1051.
38. Dowell FJ, Henrion D, Benessiano J, Poitevin P, Levy B: Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J Hypertens 1996, 14:177-182.
39. ++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of α1-receptors. J Pharmacol Exp Ther 1984, 230:413-418.
40. i and ionic currents in cultured bovine aortic endothelial cells. Circ Res 1987, 61:632-640.
41. Takeda K, Schini V, Stoeckel H: Voltage-dependent and agonist activated ionic currents in vascular endothelial cells. Blood Vessels 1990, 27:169-183.
42. Adeagbo ASO, Okpako DT: Mechanism of noradrenaline potentiation by prostaglandin E2 in rat mesenteric artery. Br J Pharmacol 1980, 71:75-81.
43. Purdy RE, Weber MA: Angiotensin II amplification of α-adrenergic vasoconstriction: role of receptor reserve. Circ Res 1988, 63:748-757
44. Rapoport RM: Potentiation of norepinephrine-induced contraction by primary prostaglandin receptor-activation in rat aorta. Eur J Pharmacol 1993, 24:207-210
45. Cressier F, Criscione L, Hofbauer KG: Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery. Eur J Pharmacol 1995, 272:57-65.
46. Cocks TM, Kemp BK, Pruneau D, Angus JA: Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist: U46619. Br J Pharmacol 1993, 110:360-368.
47. Angus JA, Brazenor RM: Relaxation of large coronary artery by verapamil, D600 and nifedipine is constrictor selective: comparison with glyceryl trinitrate. J Cardiovasc Pharmacol 1983, 5:321-328.
48. Lariviere R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995, 8:294-300.
49. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al.: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990, 15:493-496.
50. Touyz RM, Deng L-Y, Li J-S, Schifrin EL: Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats. J Hypertens 1996, 14:983-991.